Delivery Order SPE2DB22D2007-SPE2DB24FJ4TE

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $5,528.55 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 32 mg Candesartan Cilexetil tablets in 90-count bottles, with a completion date of September 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999, which provides a range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $3,161.92, is a delivery order for the supply of Candesartan Cilexetil 16 mg tablets. This order is not set aside for any specific business types. The award has an ultimate completion date of August 13, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,575.64, is for the delivery of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,503.85 firm fixed-price delivery order contract is for the supply of 4,567,213,611 units of Candesartan Cilexetil 32 mg tablets in 90-count packages. The contract has a period of performance through February 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,528.04 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 8 mg tablets. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,267.99 Firm Fixed Price Delivery Order is for the supply of 4,566,708,800 units of Candesartan Cilexetil 16 mg Tablets in 90-count packages. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Candesartan Cilexetil 8 mg tablets in 90-count packages. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,227.13 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets. The contract is not set-aside and has an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,824.15 delivery order contract is for the provision of Candesartan Cilexetil 32 mg tablets. The contract has a firm fixed price pricing type and runs through November 13, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,053.09, is for the delivery of candesartan cilexetil 32 mg tablets. It is a firm-fixed-price delivery order contract that runs through March 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ4TE
    Delivery Order

This federal contract award is for the delivery of Candesartan Cilexetil 16 mg tablets in 90-count packages. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The total contract ceiling value is $4,404.34, and the award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. The contract does not have a set-aside designation, and the ultimate completion date is August 2, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to provide a wide range of prescription medications, over-the-counter drugs, and medical supplies to various government agencies and healthcare programs, including the military and federal healthcare providers.

Generated 10/31/24, 9:56 AM